Third time’s the charm: Fangzhou finally finds winning tonic for Hong Kong IPO
The company has become the latest internet healthcare stock to list, but continues to lose money and remains heavily reliant on drug sales Key Takeaways: Fangzhou has been approved to…
Recent Articles
RELATED ARTICLES
-
Ping An Health pins recovery hopes on new leadership
1833.HK - Margins ring alarm bells as 160 Health readies IPO
-
IFlytek hives off health unit to fund AI medical drive
002230.SHE
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Everest reaches new heights on growing drug sales
1952.HK
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
